{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9e54509d9daa","filters":{"venue":"International Journal of Pharmaceutical and Biological Science Archive"}},"results":[{"id":"W3175943885","doi":"","title":"COMPARISON OF NEW DRUG APPROV AL PROCEDURES AND REGULATORY STRUCTURES IN TURKEY AND CANADA","year":2013,"lang":"en","type":"article","venue":"International Journal of Pharmaceutical and Biological Science Archive","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Marketing authorization; Authorization; Business; Regulatory affairs; Drug; Clinical trial; Process (computing); Drug development; Drug approval; New drug application; Marketing; Innovator; Regulatory science; Public relations; Medicine; Pharmacology; Political science; Public administration; Finance; Computer security; Computer science","authors":[{"name":"Abhisek Shukla","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.282813803385231,"gpt":0.5394769818318773,"spread":0.2566631784466463,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004157677,0.0002949183,0.0003600305,0.005266315,0.003153186,0.005008839,0.001352778,0.001005659,0.007738771],"category_scores_gemma":[0.01210539,0.000432386,0.0009363542,0.005681159,0.001685791,0.0009355689,0.001084821,0.001410944,0.0007466204],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0752046,"about_ca_system_score_gemma":0.1153809,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9465078,"about_ca_topic_score_gemma":0.9664962,"domain_scores_codex":[0.9896774,0.0008045356,0.0006603863,0.0007338179,0.005388022,0.002735817],"domain_scores_gemma":[0.9796897,0.002640773,0.002026439,0.000417422,0.01293729,0.002288325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003269845,0.0005562048,0.2639041,0.002407799,0.0004661231,0.003314847,0.006716959,0.007969395,0.004902752,0.2742342,0.09753527,0.3347225],"study_design_scores_gemma":[0.0002473778,0.0003557138,0.6937999,0.0009376517,0.000386568,0.001331497,0.007287096,0.003909202,0.003762058,0.002084166,0.2856092,0.0002895948],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5816572,0.03038542,0.00382972,0.0143529,0.0005995423,0.001009918,0.009512518,0.0004559198,0.3581968],"genre_scores_gemma":[0.9448982,0.008870081,0.003013551,0.002381297,0.00006721656,0.0001478514,0.002927077,0.0001357811,0.03755895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9247954,"threshold_uncertainty_score":0.5456501,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}